BioEurope Spring

This premier springtime partnering conference bringing together a “whoʼs who” from biotech, pharma and finance in Europe's most innovative biopharma clusters. 

Keith Thompson, CEO at Cell and Gene Therapy Catapult, will be participating in the pannel titled Regenerative medicines and their impact on healthcare: From lab to market on Tuesday 21 March, 10:15-11:45. 

Members of the Cell and Gene Therapy Catapult team will be the event. Please contact us if you would like to arrange a meeting. 

  • FDA approves , a one-time AAV gene therapy indicated for the treatment of patients with a rare form of inh… 1 hour 7 min ago

Discover who we are